Given the increasing global prevalence of thyroid disorders, session has been organized to explore the latest clinical guidelines. In this session, Prof. Susan Mandel, Prof. Eun Kyung Lee, and Prof. Eu Jeong Ku will present lectures on key aspects of the most recent guidelines from the American Thyroid Association and the Korean Thyroid Association. This aim of this session is to provide healthcare professionals with an overview of the current trends in thyroid disorders and offer practical knowledge applicable to clinical settings.

This session aligns with the theme of SICEM 2024, ‘One Endo.' It features three lectures on thyroid hormone disorders and metabolic diseases. Prof. Rohit A. Sinha will discuss the relationship between thyroid hormones and non-alcoholic fatty liver disease. Prof. Hyon-Seung Yi will introduce the role of IL-17A-producing γδ T cells in metabolic complications of thyrotoxicosis. Lastly, Prof. Yong-Ho Lee will cover the association between thyroid function and metabolic parameters.

In this session, we invited distinguished researchers to share their cutting-edge insights into the treatment of Graves' disease. Prof. Ken Okamura will deliver a lecture on the long-term prognosis of Graves' disease and explore the effectiveness and safety of prolonged anti-thyroid drug therapy. Prof. Jae Hoon Moon will introduce the incorporation of recent trends in artificial intelligence and wearable technology into the treatment of Graves' disease. Finally, Prof. Jin Sook Yoon will present the recent advancements in the treatment of thyroid eye disease, including newly developed drugs such as IGF-1 receptor antagonists.